Navigation Links
Palatin Technologies and King Pharmaceuticals Announce Plan To,Present Results of Bremelanotide Phase 2b Studies in Men With,Erectile Dysfunction

t ED

ED is defined as the consistent inability to attain and maintain an erection sufficient for sexual intercourse. The condition is correlated with increasing age, cardiovascular disease, hypertension, diabetes, hyperlipidemia, and smoking. In addition, certain prescription drugs and psychogenic issues may contribute to ED. It is estimated that some degree of ED affects one half of all men over the age of 40 and that 150 million men worldwide suffer from ED.

About Palatin Technologies, Inc.

Palatin Technologies, Inc. is a biopharmaceutical company focused on discovering and developing targeted, receptor-specific small molecule and peptide therapeutics. Palatin's lead product candidate, bremelanotide, is currently in Phase 2 clinical trials for both male and female sexual dysfunction. Palatin's internal research and development capabilities, anchored by its proprietary MIDAS(TM) technology, are fueling product development. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. To date, Palatin has entered into collaborations with AstraZeneca, King Pharmaceuticals, and Tyco Healthcare Mallinckrodt. For additional information regarding Palatin, please visit Palatin Technologies' website at http://www.palatin.com.

About King Pharmaceuticals, Inc.

King, headquartered in Bristol, Tennessee, is a vertically integrated branded pharmaceutical company. King, an S&P 500 Index company, seeks to capitalize on opportunities in the pharmaceutical industry through the development, including through in-licensing arrangements and acquisitions, of novel branded prescription pharmaceutical products in attractive markets and the strategic acquisition of branded products that can benefit from focused promotion and marketing and product life-cycle management.

Forward-looking Statements

<
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Palatin Technologies and King Pharmaceuticals Report Data Showing Improvements in Sexual Relationship and Self-Esteem in Patients with Erectile Dysfunction Treated with Bremelanotide
2. Neose Technologies to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
3. New Report Looking at Chiral Technologies Analyzes the Global Market Growth Forecasts Driven By Two Very Important Components as Single Isomer Drugs and Single Enantiomer Pharmaceuticals
4. Genelabs Technologies Announces Presentation of Data on Non-Nucleoside HCV Polymerase Inhibitor at 20th International Conference on Antiviral Research Meeting
5. Micell Technologies Presents Data on Novel Drug-Eluting Stents
6. OncoGenex Technologies Announces Phase II Data of OGX-011 in Metastatic Breast Cancer at American Association for Cancer Research 2007 Annual Meeting
7. AVAX Technologies Presents Results of Phase I-II M-Vax Trial at Annual Meeting of American Association for Cancer Research
8. Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery of GLP-1 and PYY
9. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
Post Your Comments:
(Date:4/1/2015)... , April 1, 2015  The U.S. ... AirStrip® Sense4Baby™ wireless maternal/fetal monitoring ... U.S. by pregnant patients to self-administer non-stress tests ... from the FDA for use accompanied by medical ... the European Commission in 2013 for self-administration, including ...
(Date:4/1/2015)...  Egalet Corporation (Nasdaq: EGLT ) ("Egalet"), ... developing, manufacturing and marketing innovative pain treatments, today ... million aggregate principal amount of its convertible senior ... placement to qualified institutional buyers pursuant to Rule ... amended (the "Act"). Egalet also granted the initial ...
(Date:4/1/2015)... 1, 2015   Advocates for Responsible Care , ... health care professionals, patient advocates and human rights specialists, ... will go live at 9:00 a.m. today. ... Reach is a new campaign to limit rising out-of-pocket ... by Advocates for Responsible Care, in partnership with the ...
Breaking Medicine Technology:AirStrip Sense4Baby System Receives FDA Clearance for Patient Self-Administration 2AirStrip Sense4Baby System Receives FDA Clearance for Patient Self-Administration 3AirStrip Sense4Baby System Receives FDA Clearance for Patient Self-Administration 4Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 2Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 3Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 4Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 5Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 6Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 7'Rx in Reach' Campaign Launches in Georgia 2'Rx in Reach' Campaign Launches in Georgia 3
... Inc. announced today that a new audio ... developer of medical technologies for diabetes management, ... heard at http://smallcapvoice.com/blog/2-8-12-smallcapvoice-interview-with-positiveid-corporation-otcbb-psid . ... firm, with clients nationwide, known for its ...
... 2012  As part of its ongoing restructuring process, Optimum ... subsidiaries as wholly owned subsidiaries of iMD Companies Inc., ... wholly owned subsidiary of Optimum Mobile Imaging Corp. (ICBU). ... LLC, will now reside alongside the newly formed Positive ...
Cached Medicine Technology:A New Audio Interview with PositiveID Chairman and CEO, William J. Caragol, is now at SmallCapVoice.com 2Optimum Mobile Imaging Corp. (ICBU) Retains Securities Law Firm 2
(Date:4/1/2015)... IL (PRWEB) April 01, 2015 ... was joined by other First Spouses from across ... event on March 21, 2015, World Down Syndrome ... for, the rapidly advancing area of Down syndrome ... participating states included Alabama, Alaska, American Samoa, Arizona, ...
(Date:4/1/2015)... 2015 BioPlus Specialty Pharmacy ... has released a new app to keep health care ... chronic hepatitis C virus (HCV) infection. This ‘HCV Treatment ... from the American Association for the Study of Liver ... new direct-acting oral medications to treat HCV have been ...
(Date:4/1/2015)... Vancouver, BC (PRWEB) April 01, 2015 ... recently announced that she is now offering her patients ... and services. Patients can participate in “Beauty Days”, which ... year by Dr Roz Kamani’s Kitsilano Skin Care Clinic. ... will directly tell patients about the latest products and ...
(Date:4/1/2015)... FL (PRWEB) April 01, 2015 South ... received Provisional Certificate of Authority (PCOA) approval from the ... step in the ongoing development of a retirement community ... individual health, wellness and spiritual development. , America’s aging ... to meet the housing needs of seniors, according to ...
(Date:4/1/2015)... Health Advocate™, Inc., the nation’s leading healthcare ... Corporation, today launched its new Health and Wellness Blog. ... the Health Advocate member website, features timely and reliable ... , “We’re pleased to introduce this new blog and ... Rosen, Executive Vice President, Health Advocate. “The blog is ...
Breaking Medicine News(10 mins):Health News:Governor First Spouses Join with New Jersey First Lady Mary Pat Christie to Support Advances in Biomedical Research to Treat Down Syndrome Cognitive Impairment 2Health News:BioPlus Specialty Pharmacy Releases ‘HCV Treatment Path’ App for Hepatitis C Providers 2Health News:Dr Roz Kamani Now Offers Patients The Opportunity to Learn About Latest Products and Services 2Health News:Casa Sant’Angelo Receives Approval for New Retirement Living 2Health News:Health Advocate Launches New Health and Wellness Blog 2
... ... , ... 2010 -- Citywide Cleaning Services - a division of Citywide Ventures Ltd and one of ... any new cleaning contracts. Also, the Company announced that it will give a £25.00 M&S ...
... genetic pattern that predicts the likelihood of relapse in ... childhood leukemia has been discovered. Researchers publishing in the ... a consistent pattern in five genes that has the ... benefit from more aggressive treatment when first diagnosed with ...
... ... save money through better contract management by reduciing their internal expenses, external expenses, and ... ... new features allowing holding companies to take advantage of the industry leading contract management ...
... uniform standards for diagnosing a food allergy even exist, ... -- There,s a lack of consistent information about the ... researchers who reviewed data from 72 studies. , The ... peanuts, tree nuts, fish and shellfish, which account for ...
... Health Sciences Center announced today that it has received ... & Melinda Gates Foundation. The grant will support ... K. Joshi, assistant professor in the Department of Microbiology ... Strategy for Immune Intervention." Joshi,s project is one ...
... moves toward the goal of a secure nationwide health information ... a framework for evaluating the costs, effort and value of ... The study, which appears in the May/June 2010 issue ... also reports on the initial assessment of that framework by ...
Cached Medicine News:Health News:Cleaning Service Pricing Discount 2Health News:Genetic pattern that predicts leukemia relapse discovered 2Health News:Network Contract Solutions Adds Holding Company Features to Extend Market Reach and Client Base 2Health News:Few High-Quality Studies on Food Allergies, Say Reviewers 2Health News:OUHSC receives $100,000 Grand Challenges Explorations grant for innovative global health research 2Health News:Measuring success: Regenstrief helps assess value of investment in health info tech 2
... Intravascular Mikro-Tip Pressure Catheters; Millar manufactures ... pressure sensor catheters for simultaneous high ... suitable for measuring pressure gradients across ... a vascular stenosis. The catheters are ...
... These dual pressure sensor catheters ... injection, slow-speed injection/guide wire, or ... SPC-784A for high-speed injection has ... openings and an open-end pigtail ...
... Sensor Intravascular Mikro-Tip Pressure Catheters; Millar ... dual pressure sensor catheters for simultaneous ... are suitable for measuring pressure gradients ... across a vascular stenosis. The catheters ...
... Percutaneous Thrombectomy Catheter is a multi-lumen, ... effective and easy removal of fresh, ... HYDROLYSER provides an efficient, patient-friendly alternative ... Compatible with your existing contrast ...
Medicine Products: